Some studies have shown that circulating ApoA-I levels in AD patients are decreased (Merched et al., 2000), while other studies have shown that circulating ApoA-I levels in AD patients are increased (Kuriyama et al., 1992,Demeester et al., 2000). This evidence concerns the gene APOA1 and Alzheimer disease.